- Published at
- by themarketherald.com.au
neutral
neutral
Wednesday’s HotCopper Trends: Galan bags funds, Prescient’s FDA tick | April 16, 2025
The ASX has been up 0.22% higher at 7,778 points in morning…
News for Prescient Therapeutics Limited (PTX.AX)
- Published at
- by gurufocus.com
positivepositivePrescient Therapeutics Ltd Meeting on the Mesa Transcript
Oct 21, 2022 / NTS GMTSteven Yatomi-Clarke - Prescient Therapeutics Limited - CEO, MD Hi, everyone. Thanks for coming, and thanks for the opportunity to present- Published at
- by gurufocus.com
positivepositivePrescient Therapeutics Ltd Investor Presentation Transcript
Sep 27, 2022 / 02:00AM GMTPresentationSep 27, 2022 / 02:00AM GMT =====================Corporate Participants===================== * Steven Yatomi-Clarke- Published at
- by gurufocus.com
positivepositivePrescient Therapeutics Ltd at Small Caps to discuss the company's plans for its innovative cancer therapies PTX-100 and PTX-200. Transcript
Sep 08, 2022 / NTS GMTKerry Stevenson - Small Caps - Moderator Welcome to Small Caps, ladies and gentlemen. My name is Kerry Stevenson. Today I'm speaking with- Published at
- by gurufocus.com
positivepositivePrescient Therapeutics Ltd Investor Briefing Transcript
Jun 10, 2022 / 02:30AM GMTPatrick Nelson - ReachCapital Pty Ltd - CEO/MD Good afternoon everyone and welcome to Prescient Therapeutics special investor briefin- Published at
- by gurufocus.com
neutralneutralPrescient Therapeutics Ltd T Small Caps to Discuss the Company's Innovative Pipeline of Personalised Cancer Therapies Transcript
Aug 12, 2021 / NTS GMTKerry Stevenson - Small Caps - Moderator Welcome back to Small Caps. My name is Kerry Stevenson. Today, we're bringing you Prescient Thera- Published at
- by themarketherald.com.au
positivepositiveASX Today: Stocks to watch on Monday
The ASX is set to rise with ASX200 futures up 0.22 per cent near 8:30 am AEDT.- Published at
- by smallcaps.com.au
mixedmixedPrescient Therapeutics to present OmniCAR and CellPryme abstracts at international gene therapy conference
Clinical stage oncology company Prescient Therapeutics (ASX: PTX) will present two of its abstracts at an annual conference of the International Society of Cell & Gene Therapy (ISCT) in France later this month.- Published at
- by stockhead.com.au
mixedmixedCRITERION: The ASX cancer fighters with a sting in their treatment tails
Early-stage developers of a new cancer immunotherapy have caught the eye of investors after some promising clinical news.- Published at
- by stockhead.com.au
neutralneutralHealth Kick Podcast: Prescient Therapeutics’ PTX-10 continues to show encouraging results following FDA Orphan Drug Designation
PTX-100 is a first in class compound with the ability to block an important cancer growth enzyme known as geranylgeranyl transferase-1.- Published at
- by stockhead.com.au
positivepositivePrescient Therapeutics hopes to accelerate bid for US FDA study approval for targeted therapy PTX-100
Prescient Therapeutics (ASX:PTX) hopes to follow the footsteps of Neuren Pharmaceuticals after positive results from Phase 1b clinical trial.- Published at
- by stockhead.com.au
mixedmixedRise and Shine: Everything you need to know before the ASX opens
Rise and Shine: Everything you need to know before the ASX opens- Published at
- by smallcaps.com.au
mixedmixed- Published at
- by stockhead.com.au
mixedmixedWeekly Small Caps and IPO Wrap: Negging the US economy won’t make it pick up, Mr Powell.
The ASX has finished lower for the week, after both Materials and Energy were brutalised while markets shook, both here and abroad.- Published at
- by stockhead.com.au
mixedmixedRise and Shine: Everything you need to know before the ASX opens
On Stockhead today, Resources Sector stocks dominate of the March S&P/ASX 300 rejig, and we meet the All Ords shiny new lithium juniors.- Published at
- by stockhead.com.au
mixedmixedCLOSING BELL: Corruption? In Africa? Over mining licences? That can’t be right, surely…
The ASX finished flat today, tech stocks surged but it was Prescient Therapeutics (ASX:PTX) winning the day on fantastic cancer drug news.- Published at
- by stockhead.com.au
mixedmixedASX Small Caps Lunch Wrap: Anyone else feel like the wheels are about to come off today?
Aussie markets may be flat this morning, but Prescient Therapeutics (ASX:PTX) is soaring on huge news for its PTX100 cancer drug.- Published at
- by stockhead.com.au
mixedmixedTop 10 at 10: Gold, nickel finds and Orphan Drug Designation for a pharmaceutical player
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.- Published at
- by globenewswire.com
mixedmixedProactive news headlines including Horizon Minerals, Stelar Metals, Prescient Therapeutics and Volt Resources
Sydney, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered...- Published at
- by stockhead.com.au
mixedmixed